EPA Incorporates Society Recommendations in Landmark PFAS Regulation

  • Apr 2023

The U.S. Environmental Protection Agency (EPA) issued a landmark regulation to set exposure limits for several per- and polyfluoroalkyl substances (PFAS) substances including PFOS and PFOAS found in drinking water.

The proposed regulation sets an aggressive limit for these PFAS and their mixtures and acknowledges effects at extremely low levels by proposing a health-based Maximum Contaminant Level Goal (MCGL) of zero. This is the first time the government has regulated a new chemical in drinking water in more than 30 years.

We are encouraged by the new regulation and hopeful that this will lead to safer drinking water for communities in the United States and support for additional research to understand the health impacts of these and other chemicals.

The Endocrine Society urged EPA to improve upon its draft rule in 2022 by including other PFAS (beyond PFOA and PFOS) in the final rule and consider low-dose effects by recognizing that there may be no safe level of exposure to these chemicals.

We are encouraged by the new regulation and hopeful that this will lead to safer drinking water for communities in the United States and support for additional research to understand the health impacts of these and other chemicals.

You may also like

  • Endocrine Society Weighs in on MPFS; Urges Congress to Avert Scheduled Medicare Cuts

    Each year, the Center for Medicare and Medicaid Services (CMS) releases the Medicare Physician Fee Schedule (MPFS) rule, which outlines the agency’s payment and quality program policies for the upcoming year. Medicare policy often sets the bar for the private insurance market as well. Therefore, the payment policies and other revisions in the MPFS are…

  • Endocrine Society Urges Congress to Complete NIH Appropriations by December 16th Deadline

    The Endocrine Society is committed to advocating for increases in the budget of the National Institutes of Health (NIH). Our Hill days, advocacy campaigns, and meetings with appropriators have contributed to increases in the NIH budget over the past seven years. Continued investment in the NIH is critical to further our understanding of endocrine disorders…

Find more in